&Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8M Buy
57,214
+3,957
+7% +$698K 0.03% 458
2026
Q1
$9.58M Buy
53,257
+7,009
+15% +$1.2M 0.05% 340
2025
Q4
$6.54M Buy
46,248
+43,523
+1,597% +$4.94M 0.03% 412
2025
Q3
$2.8M Buy
+2,725
New +$210K 0.02% 617
2025
Q2
Sell
-3,423
Closed -$247K 1994
2025
Q1
$247K Sell
3,423
-4,231
-55% -$344K ﹤0.01% 1512
2024
Q4
$673K Buy
7,654
+1,668
+28% +$166K 0.01% 935
2024
Q3
$567K Buy
+5,986
New +$531K 0.01% 805

Other funds holding ALB

&Partners's ALB Position: Q2 2026 in Review

&Partners increased its Albemarle (ALB) stake by 7.4% in Q2 2026, buying an estimated $698K and bringing the position to 57,214 shares worth $7.8M. The position accounts for 0.03% of the portfolio, ranked #458.

&Partners first reported a position in ALB in Q3 2024 and has held it in 7 quarters since. The position peaked at $9.58M in Q1 2026. 937 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • &Partners held 57,214 shares of Albemarle worth $7.8M as of Q2 2026.
  • &Partners bought 3,957 Albemarle shares in Q2 2026, an estimated $698K.
  • Albemarle made up 0.03% of &Partners's portfolio in Q2 2026, its #458 holding.
  • &Partners first reported a position in Albemarle in Q3 2024 and has held it in 7 quarters since.
  • &Partners's Albemarle position peaked at $9.58M in Q1 2026.
  • 937 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.